scholarly journals Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence

1978 ◽  
Vol 37 (4) ◽  
pp. 491-496 ◽  
Author(s):  
D W Hedley ◽  
T J McElwain ◽  
G A Currie
Keyword(s):  
Malignant Melanoma ◽  
Early Recurrence ◽  
Active Immunotherapy ◽  
Specific Active Immunotherapy

scholarly journals Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Javier Sánchez Ramírez ◽  
◽  
Yanelys Morera Díaz ◽  
Mónica Bequet-Romero ◽  
Francisco Hernández-Bernal ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Humoral Response ◽  
Active Immunotherapy ◽  
Compassionate Use ◽  
Specific Active Immunotherapy ◽  
Specific Humoral Response

scholarly journals Antigen-specific active immunotherapy for ovarian cancer

2018 ◽  
Author(s):  
Sterre T Paijens ◽  
Ninke Leffers ◽  
Toos Daemen ◽  
Wijnand Helfrich ◽  
H Marike Boezen ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Active Immunotherapy ◽  
Specific Active Immunotherapy

scholarly journals Controlled trial of active immunotherapy in management of stage IIB malignant melanoma.

BMJ ◽  
1977 ◽  
Vol 1 (6060) ◽  
pp. 540-542 ◽  
Author(s):  
M B McIllmurray ◽  
M J Embleton ◽  
W G Reeves ◽  
M J Langman ◽  
M Deane
Keyword(s):  
Malignant Melanoma ◽  
Controlled Trial ◽  
Active Immunotherapy
Sign in / Sign up

Export Citation Format

Share Document